Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune-checkpoint inhibitors

There is a lack of real-world data on the use of cabozantinib in Asian patients with metastatic renal cell carcinoma. We conducted a retrospective study to investigate the toxicity and efficacy of cabozantinib in this patient population who progressed on tyrosine kinase inhibitors and/or immune-chec...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drugs in Context 2023-06, Vol.12, p.1-9
Hauptverfasser:	Poon, Darren Mc, Chan, Kuen, Leung, Angus Kwong-Chuen, Ng, Brian, Cheung, Foon-Yiu, Siu, Steven Wai-Kwan
Format:	Artikel
Sprache:	eng
Schlagworte:	immuno-oncology metastatic renal cell carcinoma Original Research real-world effectiveness sequential therapies targeted therapy tyrosine kinase inhibitors vascular endothelial growth factor receptor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!